Last price paid | 0.24 | |
Change | -4.00% [ -0.01 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 07.06.2024 17:20 |
Fixing | n.a. |
Settlement date | 10.11.2023 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +11.90% |
Year to date (YTD) | -14.29% |
1 month | -17.24% |
3 months | -40.00% |
1 year | n.a. |
3 years | n.a. |
Issue price | 0.21 |
Underlying price on issue | 39.50 |
Premium | 0.02% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1281039359 |
Symbol | IBI7ZZ |
Security | 128103935 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | BB Biotech N, CH0038389992 |
Underlying ISIN | CH0038389992 |
Funding level | 31.371600 |
Stop-loss level | 32.292600 |
Distance to stop-loss level | 19.37% |
Long/Short type | Long |
Subscription ratio | 40.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 08.11.2023 |
Premium | 1.80% |
Premium p.a. | n.a. |
Leverage | 4.26 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 8.678400 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
ROCHE GS | 242.60 |
Compagnie Financi... | 150.10 |
Swiss Re | 113.65 |
Holcim | 79.98 |
Alcon AG | 82.16 |
Name | Price |
---|---|
Partners Group Ho... | 1'165.00 |
Lonza Group | 500.20 |
Sika AG | 270.90 |
GEBERIT N | 550.80 |
SWISSCOM N | 503.50 |